You are here

clinical trials

Immunicum's dendritic cell therapy flunks co-primary endpoint in 'positive' PhII

Immunicum's dendritic cell therapy flunks co-primary endpoint in 'positive' PhII

Endpoints

metastatic kidney cancer

clinical trials

Flag link:

One year after flop, AstraZeneca's phase 3 lupus trial hits endpoint

One year after flop, AstraZeneca's phase 3 lupus trial hits endpoint

Fierce Biotech

clinical trials

systemic lupus erythematosus

Flag link:

FDA Finalizes Guidance on Placebos and Blinding for Cancer Trials

FDA Finalizes Guidance on Placebos and Blinding for Cancer Trials

RAPS.org

clinical trials

Flag link:

FDA Urges Inclusion Of Men In Breast Cancer Clinical Trials

FDA Urges Inclusion Of Men In Breast Cancer Clinical Trials

Forbes

male breast cancer

clinical trials

Flag link:

Santhera's Duchenne effort gets a boost on positive PhIIa for alternative steroid vamorolone — though there's a lot left to prove

Santhera's Duchenne effort gets a boost on positive PhIIa for alternative steroid vamorolone — though there's a lot left to prove

Endpoints

Duchenne Muscular Dystrophy

clinical trials

Flag link:

Medicines Company's PCSK9 drug hits phase 3 efficacy goals

Medicines Company's PCSK9 drug hits phase 3 efficacy goals

Fierce Biotech

Medicines Company

clinical trials

Flag link:

Teva’s CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial

Teva’s CGRP-Inhibitor Reduced Monthly Migraine Days in Late-Stage Trial

BioSpace

Teva Pharmaceutical

clinical trials

Flag link:

Synlogic falls as it axes lead program

Synlogic falls as it axes lead program

BioCentury

clinical trials

Flag link:

Futility analysis augurs defeat in pivotal trial testing of NuCana's lead drug in metastatic pancreatic cancer

Futility analysis augurs defeat in pivotal trial testing of NuCana's lead drug in metastatic pancreatic cancer

Endpoints

clinical trials

metastatic pancreatic cancer

Flag link:

Juvenescence raises $100M to fund longevity assets to early readouts

Juvenescence raises $100M to fund longevity assets to early readouts

Fierce Biotech

clinical trials

Flag link:

Many clinical trials for new cancer drugs didn’t include any data on race

Many clinical trials for new cancer drugs didn’t include any data on race

Stat

clinical trials

racial diversity

Flag link:

The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries

The real-world evidence project at the FDA adds Syapse to its list of partners in a push past trial boundaries

Endpoints

clinical trials

real world evidence

Flag link:

Ailing Mallinckrodt's drug for rare, life-threatening renal condition clears pivotal study

Ailing Mallinckrodt's drug for rare, life-threatening renal condition clears pivotal study

Endpoints

clinical trials

hepatorenal syndrome

Flag link:

Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy

Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy

Fierce Biotech

Ziopharm Oncology

clinical trials

Flag link:

$60M B round to propel Landos through Phase II IBD trials

$60M B round to propel Landos through Phase II IBD trials

BioCentury

Landos Biopharma

clinical trials

ulcerative colitis

Crohn's Disease

Flag link:

AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment

AZ/MSD’s PARP inhibitor shows promise as first-line ovarian cancer treatment

Pharmaforum

clinical trials

advanced ovarian cancer

Flag link:

Deciphera soars as phase 3 cancer data tee up FDA filing

Deciphera soars as phase 3 cancer data tee up FDA filing

Fierce Biotech

clinical trials

gastrointestinal stromal tumors

Flag link:

Experts Seek Tweaks to FDA Draft Guidance on Clinical Trial Diversity

Experts Seek Tweaks to FDA Draft Guidance on Clinical Trial Diversity

RAPS.org

clinical trials

real world data

real world evidence

Flag link:

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

Pharmaceutical Business Review

clinical trials

Flag link:

89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team

89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team

CP WIre

clinical trials

Flag link:

Pages